Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection [5]

Clinical Chemistry

Volumn 51, Issue 1, 2005, Pages 274-276

  Meisser, Arielle ^a   Cohen, Marie ^a   Bischof, Paul ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Laboratoire d'Hormonologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITRATE SODIUM; EDETIC ACID; GELATINASE; GELATINASE A; GELATINASE B; HEPARIN; PROTEINASE; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ANALYTIC METHOD; BLOOD CELL; BLOOD SAMPLING; CANCER PATIENT; CELL ISOLATION; CENTRIFUGATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; IMMUNOREACTIVITY; LETTER; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SUPERNATANT; TECHNIQUE; ZYMOGRAPHY;

BLOOD SPECIMEN COLLECTION; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; REFERENCE VALUES;

EID: 11144346937     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.041707     Document Type: Letter

References (8)

1. Riedel F, Gotte K, Schwalb J, Hormann K. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Anticancer Res 2000;20:3045-9.
2. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y, et al. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 1996;24:1058-62.
3. Jung K, Laube C, Lein M, Lichtinghagen R, Tschesche H, Schnorr D, et al. Kind of samples as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin Chem 1998;44:1060-2.
4. Jung K, Lein M, Laube C, Lichtinghagen R. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta 2001;314:241-4.
5. Mannello F, Luchetti F, Canonico B, Papa S. Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases. Clin Chem 2003;49:1956-7.
6. Makowski GS, Ramsby ML. Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma. Anal Biochem 2003;322:283-6.
7. Meisser A, Chardonnens D, Campana A, Bischof P. Effects of tumor necrosis factor α, interleukin-1 α, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999;5:252-60.
8. Martelli, M, Campana, A, Bischof, P. Secretion of matrix metalloproteinases by human endometrial cells in vitro. J Reprod Fertil 1993;98:67-76.